Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    "Bowens disease"
Show Display Options
RSS Create an RSS feed from your search for:
"Bowens disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Topical Imiquimod for Bowen's Disease of the Head and Neck
Condition: Bowens Disease
Intervention: Drug: Imiquimod
2 Completed Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease
Condition: Bowen's Disease
Interventions: Drug: Er:YAG AFL-PDT;   Drug: MAL-PDT
3 Terminated Trial of Excision Versus Photodynamic Therapy in the Treatment of Bowen's Disease
Condition: Bowen's Disease
Interventions: Procedure: excision;   Procedure: Photodynamic therapy
4 No longer available Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease
Conditions: Field Actinic Keratoses;   Basal Cell Carcinoma;   Bowen's Disease
Intervention: Drug: Metvix (methyl aminolevulinate)
5 Completed Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis
Conditions: Actinic Keratosis;   Bowen's Disease
Intervention: Drug: SR-T100 ® Gel
6 Unknown  Effects of Arsenic on Keratinocytes in a Skin Equivalent Model
Condition: Bowen Disease
Intervention: Procedure: foreskin from healthy adults for organotypic culture
7 Completed PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin Cancer
Conditions: Actinic Keratosis;   Warts;   Basal Cell Carcinoma;   Bowens Disease;   Squamous Cell Carcinoma
Intervention: Procedure: Photodynamic therapy with Metvix 160 mg/g cream
8 Completed Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ
Condition: Carcinoma, Squamous Cell
Intervention: Drug: PEP005
9 Completed Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
Conditions: Lymphoma;   Non-melanomatous Skin Cancer;   Precancerous Condition
Intervention: Drug: silicon phthalocyanine 4

Indicates status has not been verified in more than two years